- Filed
- Mar 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Mar 14, 2024 | 4.46M sh |
| Long Term Debt | Q1 2024 · Jan 31, 2024 | $2.97M |
| Long Term Debt | Q1 2024 · Oct 31, 2023 | $2.95M |
| Short Term Debt | Q1 2024 · Jan 31, 2024 | $825.65K |
| Short Term Debt | Q1 2024 · Oct 31, 2023 | $480K |
| Current Liabilities | Q1 2024 · Jan 31, 2024 | $7.99M |
| Current Liabilities | Q1 2024 · Oct 31, 2023 | $4.85M |
| Total Liabilities | Q1 2024 · Jan 31, 2024 | $12.19M |
| Total Liabilities | Q1 2024 · Oct 31, 2023 | $9.43M |
| Current Assets | Q1 2024 · Jan 31, 2024 | $2.29M |
| Current Assets | Q1 2024 · Oct 31, 2023 | $3.18M |
| Total Assets | Q1 2024 · Jan 31, 2024 | $7.36M |
| Total Assets | Q1 2024 · Oct 31, 2023 | $8.34M |
| Net Income | Q1 2024 · Oct 31, 2023 | −$5.4M |
| Net Income | Q1 2024 · Jan 31, 2023 | −$1.19M |
| Shares Diluted | Q1 2024 · Jan 31, 2023 | 4.43M sh |
| Operating Cash Flow | Q1 2024 · Jan 31, 2023 | −$949.86K |
| Stockholders Equity | Q1 2024 · Jan 31, 2023 | $1.91M |
| Stockholders Equity | Q1 2024 · Oct 31, 2022 | $2.84M |
| Eps Diluted | Q1 2024 · Jan 31, 2023 | −$0.27 |
| Eps Basic restated | Q1 2024 · Jan 31, 2023 | −$0.27 |
| Sga Expense | Q1 2024 · Jan 31, 2023 | $1.42M |
| Rd Expense | Q1 2024 · Jan 31, 2023 | $6.83K |
| Operating Income | Q1 2024 · Jan 31, 2023 | −$1.15M |
| Gross Profit | Q1 2024 · Jan 31, 2023 | $277.52K |
| Cost Of Revenue | Q1 2024 · Jan 31, 2023 | $66.51K |
| Revenue | Q1 2024 · Jan 31, 2023 | $344.59K |